Nascent Biotech Inc. Quarterly Deferred Tax Assets, Net of Valuation Allowance in USD from Q1 2019 to Q1 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
-
Summary
-
Nascent Biotech Inc. quarterly Deferred Tax Assets, Net of Valuation Allowance history and growth rate from Q1 2019 to Q1 2024.
- Nascent Biotech Inc. Deferred Tax Assets, Net of Valuation Allowance for the quarter ending March 31, 2024 was $0.000.
Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)